Short answer
When designing healthcare access strategies or pharmaceutical policies, actively account for socioeconomic disparities to ensure equitable distribution and utilization of medicines.
- Field
- Sustainability
- Source
- International Journal for Equity in Health (2015)
- Method
- Multivariate logistic regression analysis supplemented by pharmaceutical policy analysis.
- Evidence
- Moderate effect
Access to and use of both prescribed and non-prescribed medicines in Central Eastern European countries is influenced by socioeconomic factors, indicating potential inequities. This sustainability research insight is drawn from a 2015 study published in International Journal for Equity in Health. Using Multivariate logistic regression analysis supplemented by pharmaceutical policy analysis., researchers explored how this design variable affects real-world outcomes. The key design takeaway: When designing healthcare access strategies or pharmaceutical policies, actively account for socioeconomic disparities to ensure equitable distribution and utilization of medicines.
Socioeconomic disparities impact medicine access and use in Central Eastern Europe.
Access to and use of both prescribed and non-prescribed medicines in Central Eastern European countries is influenced by socioeconomic factors, indicating potential inequities.
International Journal for Equity in Health · 2015
Key Findings
- 01A gradient favouring individuals from higher socioeconomic groups was observed in the consumption of non-prescribed medicines across all eight surveyed countries.
- 02This socioeconomic gradient was also found for prescribed medicines in Latvia, Poland, and Romania.
- 03Pharmaceutical systems in these countries were characterized by insufficient public funding, leading to a high reliance on private financing, including co-payments.
Application
Design takeaway
When designing healthcare access strategies or pharmaceutical policies, actively account for socioeconomic disparities to ensure equitable distribution and utilization of medicines.
How to apply
When developing public health campaigns or designing healthcare service delivery models, consider how different socioeconomic groups might experience barriers to accessing and using medicines, and design solutions to overcome these.
Project actions
- 01Consider how your design project might impact different socioeconomic groups.
- 02Investigate existing access barriers for your target users.
- 03Think about affordability and accessibility in your design solutions.
Method & Evidence
Variables
Strengths & Limitations
Strengths
- +Analyzes a range of socioeconomic determinants.
- +Includes a policy analysis alongside empirical data.
- +Covers multiple countries in Central Eastern Europe.
Limitations
The study's data is from several years ago, so current situations might differ. It also focuses on specific countries, so findings might not apply everywhere.
Reliability & validity
The use of a large-scale survey (European Health Interview Survey) and established statistical methods (multivariate logistic regression) enhances the reliability and validity of the findings regarding the association between socioeconomic status and medicine use.
Think critically
To what extent do pharmaceutical policies in your region reflect an understanding of socioeconomic determinants of health, and how could design interventions improve equity in medicine access?
Design Principles
"Equitable access to essential resources should not be determined by socioeconomic status."
Understanding how socioeconomic status affects access to essential resources like medicines is crucial for designing equitable health policies and interventions. This insight highlights the need for systemic approaches that address underlying social determinants of health to ensure fair distribution and utilization of healthcare resources.
What This Means for Your Design
This research shows that in some Eastern European countries, people with more money and education are more likely to use medicines, both prescribed and over-the-counter. This is partly because public health systems don't always cover the costs, making it harder for poorer people to get the medicines they need.
How to use in your project
- 1.Reference this study when discussing the social impact of your design or the importance of equitable access in your design process.
- 2.Use the findings to justify the need for specific features or strategies in your design that address accessibility for diverse socioeconomic groups.
Add to My Project
Quick Cite
Paragraph starter
This research highlights that socioeconomic status significantly influences medicine access and use in Central Eastern European countries, with individuals from higher socioeconomic groups showing greater consumption of both prescribed and non-prescribed medicines. This disparity is exacerbated by underfunded public health systems, leading to increased out-of-pocket expenses. When developing design solutions, it is crucial to acknowledge and address these socioeconomic determinants to ensure equitable access and prevent the marginalization of certain user groups.
Source
International Journal for Equity in Health
Inequalities in medicine use in Central Eastern Europe: an empirical investigation of socioeconomic determinants in eight countries
journal · 2015
View sourceQuestions About This Research
- What does the research say about socioeconomic disparities impact medicine access and use in central eastern europe?
- When designing healthcare access strategies or pharmaceutical policies, actively account for socioeconomic disparities to ensure equitable distribution and utilization of medicines. Evidence: International Journal for Equity in Health (2015).
- Why does "Socioeconomic disparities impact medicine access and use in Central Eastern Europe." matter for design?
- Understanding how socioeconomic status affects access to essential resources like medicines is crucial for designing equitable health policies and interventions. This insight highlights the need for systemic approaches that address underlying social determinants of health to ensure fair distribution and utilization of healthcare resources.
- How can designers apply this research?
- When designing healthcare access strategies or pharmaceutical policies, actively account for socioeconomic disparities to ensure equitable distribution and utilization of medicines.
- What were the main findings?
- A gradient favouring individuals from higher socioeconomic groups was observed in the consumption of non-prescribed medicines across all eight surveyed countries.. This socioeconomic gradient was also found for prescribed medicines in Latvia, Poland, and Romania.. Pharmaceutical systems in these countries were characterized by insufficient public funding, leading to a high reliance on private financing, including co-payments.
- What research method was used?
- Multivariate logistic regression analysis supplemented by pharmaceutical policy analysis..
- How strong is the evidence?
- Evidence strength is rated Moderate effect, based on a 2015 journal from International Journal for Equity in Health.
- What should I do differently in my next project?
- When developing public health campaigns or designing healthcare service delivery models, consider how different socioeconomic groups might experience barriers to accessing and using medicines, and design solutions to overcome these.
- What are the limitations?
- The study uses data from 2007-2009, and pharmaceutical policies and socioeconomic conditions may have evolved since then. The analysis focuses on specific countries and may not be generalizable to all regions.